Compare StocksJNJ vs TMO

Johnson & Johnson (JNJ) vs Thermo Fisher Scientific Inc. (TMO): Which Is the Better Buy in 2026?

As of 2026-06-19, JNJ is fairly valued at $228, with a DCF intrinsic value of $281 and a margin of safety of 19%. TMO is overvalued at $465, with an intrinsic value of $407 and a margin of safety of -14%. Of the two, JNJ has the wider margin of safety.

JNJ
Johnson & Johnson
$228.39
VS
TMO
Thermo Fisher Scientific Inc.
$464.61

Rewards

JNJ
  • Johnson & Johnson has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • Gross margin of 68.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Johnson & Johnson scores 90/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
TMO
  • Trailing P/E of 25.5x is 21% below the historical average of 32.3x — potentially undervalued relative to its own history.
  • Altman Z-Score of 3.85 indicates very low bankruptcy risk — the company is firmly in the safe zone.

Risks

JNJ
  • Trailing P/E of 26.5x is 33% above the historical average of 20.0x — the stock trades at a premium to its own history.
  • PEG ratio of 3.06 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Insiders have sold $2.4M worth of stock in the past 3 months — significant insider liquidation.
TMO
  • 21 insider sales with no purchases over the past 12 months — a persistent pattern of insider selling.

Key Valuation Metrics

Learn more →
JNJ
TMO
Valuation
$19.31B
Free Cash Flow
$5.52B
3.51%
FCF Yield
3.20%
26.46
Trailing P/E
25.53
17.96
Forward P/E
17.05
Quality & Moat
15.32%
ROIC
6.71%
26.42%
ROE
13.52%
68.04%
Gross Margin
40.93%
3.06
PEG Ratio
1.55
Balance Sheet Safety
0.41
Net Debt / Equity
0.77
N/A
Interest Coverage
N/A
0.96
Net Debt / EBITDA
3.53
2.22%
Dividend Yield
0.40%
JNJ: 8Ties: 2TMO: 2
JNJTMO

Historical Fundamentals

Learn more →
JNJ

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

TMO

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
JNJ
$0.91
created per $1 retained over 3 years
Mediocre Allocator
Σ Retained
$40.05B
Δ Market Cap
+$36.63B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
TMO
$0.17
created per $1 retained over 3 years
Value Destroyer
Σ Retained
$17.29B
Δ Market Cap
+$2.95B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
JNJ
18.6% Margin of Safety
Price is 18.6% below estimated fair value
Current Price: $228.39
Fair Value: $280.51
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
TMO
14.3% Overvalued
Price is 14.3% above estimated fair value
Current Price: $464.61
Fair Value: $406.54
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
JNJ

What growth rate is the market pricing in at $228?

+7.7%
Market-Implied Owner Earnings Growth
Standard FCF implies +13.3%

The market implies +7.7% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +13.3%, reflecting heavy growth investment.

TMO

What growth rate is the market pricing in at $465?

+11.6%
Market-Implied Owner Earnings Growth
Standard FCF implies +16.6%

The market implies +11.6% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +16.6%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
JNJ
90/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Revenue Predictability is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
TMO
60/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with margin stability as the key competitive advantage. Improving roic consistency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
JNJ
-2.31
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
TMO
-2.47
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
JNJ
Insiders 0.1%Institutions 76.9%Retail & Other 23.1%
No. of Institutional Holders5,728
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
TMO
Insiders 0.2%Institutions 94.3%Retail & Other 5.6%
No. of Institutional Holders3,536
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
JNJ
0
Buys (3M)
1
Buys (12M)
Total value (12M): $257,688
MORIKIS JOHN G
Director
$257,688
@ $206.15 · 2025-11-26
WEINBERGER MARK A
Director
$147,220
@ $147.22 · 2024-12-12
Open market purchases · includes direct & indirect ownership · excludes option exercises
TMO
0
Buys (3M)
0
Buys (12M)
CHAI NELSON J
Director
$11,038
@ $551.90 · 2024-12-09
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
JNJ
1
Sells (3M)
13
Sells (12M)
Total value (12M): $103.65M
WENGEL KATHRYN E
Chief Technology Officer
$2.41M
@ $241.15 · 2026-06-11
DECKER ROBERT J
Officer
$1.01M
@ $247.87 · 2026-02-27
SCHMID TIMOTHY
Officer
$324,763
@ $245.66 · 2026-02-20
SCHMID TIMOTHY
Officer
$5.53M
@ $244.33 · 2026-02-18
SWANSON JAMES D
Chief Technology Officer
$15.11M
@ $243.39 · 2026-02-17
BROADHURST VANESSA
Officer
$1.51M
@ $243.39 · 2026-02-17
WOLK JOSEPH J
Chief Financial Officer
$21.77M
@ $242.80 · 2026-02-17
REED JOHN C
Officer
$13.11M
@ $243.00 · 2026-02-17
REED JOHN C
Officer
$4.19M
@ $192.71 · 2025-10-17
TAUBERT JENNIFER L
Officer
$10.04M
@ $177.81 · 2025-09-04
DUATO JOAQUIN BOIX
Chief Executive Officer
$22.55M
@ $179.21 · 2025-08-22
WOLK JOSEPH J
Chief Financial Officer
$2.98M
@ $176.91 · 2025-08-15
REED JOHN C
Officer
$3.13M
@ $163.55 · 2025-07-17
DECKER ROBERT J
Officer
$1.16M
@ $165.88 · 2025-02-25
SCHMID TIMOTHY
Officer
$62,928
@ $156.15 · 2025-02-18
WOLK JOSEPH J
Chief Financial Officer
$2.00M
@ $153.89 · 2025-02-07
DECKER ROBERT J
Officer
$930,113
@ $165.06 · 2024-08-30
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
TMO
1
Sells (3M)
21
Sells (12M)
Total value (12M): $110.57M
PETTITI GIANLUCA
President
$185,064
@ $462.66 · 2026-04-27
SHAFER MICHAEL D
Officer
$802,536
@ $499.40 · 2026-03-11
CASPER MARC N
Chief Executive Officer
$2.06M
@ $514.82 · 2026-03-05
CASPER MARC N
Chief Executive Officer
$5.08M
@ $507.75 · 2026-03-04
PETTITI GIANLUCA
Officer
$216,480
@ $541.20 · 2026-02-09
LAGARDE MICHEL
Chief Operating Officer
$12.42M
@ $563.56 · 2025-12-04
LAGARDE MICHEL
Chief Operating Officer
$36.13M
@ $582.68 · 2025-12-03
LOWERY FREDERICK M.
Officer
$8.15M
@ $589.81 · 2025-12-02
SHAFER MICHAEL D
Officer
$6.43M
@ $600.00 · 2025-11-25
LAGARDE MICHEL
Chief Operating Officer
$2.76M
@ $594.42 · 2025-11-13
BRITT LISA P
Officer
$622,136
@ $588.59 · 2025-11-12
PETTITI GIANLUCA
Officer
$1.73M
@ $580.00 · 2025-11-10
BRITT LISA P
Officer
$5.84M
@ $571.62 · 2025-11-07
CASPER MARC N
Chief Executive Officer
$13.91M
@ $571.33 · 2025-10-27
PETTITI GIANLUCA
Officer
$229,660
@ $574.15 · 2025-10-24
CASPER MARC N
Chief Executive Officer
$200,201
@ $500.50 · 2025-09-05
HOLMES JOSEPH R.
Officer
$189,662
@ $492.63 · 2025-08-29
CASPER MARC N
Chief Executive Officer
$5.01M
@ $500.96 · 2025-08-22
CASPER MARC N
Chief Executive Officer
$248,046
@ $500.09 · 2025-08-20
CASPER MARC N
Chief Executive Officer
$8.15M
@ $452.99 · 2025-08-07
PETTITI GIANLUCA
Officer
$191,992
@ $479.98 · 2025-07-25
PETTITI GIANLUCA
Officer
$164,444
@ $411.11 · 2025-05-12
PETTITI GIANLUCA
Officer
$128,979
@ $429.93 · 2025-04-28
BOXER MICHAEL A
General Counsel
$2.01M
@ $532.59 · 2025-03-10
CASPER MARC N
Chief Executive Officer
$9.33M
@ $518.16 · 2025-03-05
SHAFER MICHAEL D
Officer
$945,038
@ $530.92 · 2025-03-03
LOWERY FREDERICK M.
Officer
$9.73M
@ $531.81 · 2025-02-24
CHAI NELSON J
Director
$8,449
@ $528.06 · 2025-02-19
WILLIAMSON STEPHEN
Chief Financial Officer
$11.58M
@ $589.36 · 2025-02-04
PETTITI GIANLUCA
Officer
$175,677
@ $585.59 · 2025-02-04
CASPER MARC N
Chief Executive Officer
$10.62M
@ $531.23 · 2024-12-03
CASPER MARC N
Chief Executive Officer
$3.26M
@ $557.89 · 2024-11-01
CASPER MARC N
Chief Executive Officer
$11.01M
@ $550.51 · 2024-10-31
CASPER MARC N
Chief Executive Officer
$11.05M
@ $552.46 · 2024-10-29
PETTITI GIANLUCA
Officer
$168,048
@ $560.16 · 2024-10-25
BOXER MICHAEL A
General Counsel
$1.12M
@ $560.16 · 2024-10-25
CASPER MARC N
Chief Executive Officer
$12.17M
@ $608.45 · 2024-09-04
CASPER MARC N
Chief Executive Officer
$6.17M
@ $617.21 · 2024-07-31
CASPER MARC N
Chief Executive Officer
$9.88M
@ $606.12 · 2024-07-30
PETTITI GIANLUCA
Officer
$180,255
@ $600.85 · 2024-07-26
HOLMES JOSEPH R.
Officer
$525,484
@ $611.03 · 2024-07-26
BRITT LISA P
Officer
$2.22M
@ $613.02 · 2024-07-26
BOXER MICHAEL A
General Counsel
$1.20M
@ $600.85 · 2024-07-26
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
JNJ
FearGreed
😏Greed(62/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
TMO
FearGreed
😨Fear(40/100)

"Market is pessimistic — investigate whether fears are temporary or structural"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
JNJ
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (62)
TMO
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Fear (40)
View JNJ Full AnalysisView TMO Full Analysis

Frequently Asked Questions: JNJ vs TMO

Is Johnson & Johnson or Thermo Fisher Scientific Inc. more undervalued in 2026?

Based on our discounted cash flow model, JNJ trades at a 18.6% margin of safety (intrinsic value $281 vs. price $228), compared to TMO's -14.3% margin of safety (intrinsic $407 vs. $465).

Which stock has a wider economic moat, Johnson & Johnson or Thermo Fisher Scientific Inc.?

JNJ scores 90/100 (Wide moat), while TMO scores 60/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Which company has better free cash flow, Johnson & Johnson or Thermo Fisher Scientific Inc.?

Johnson & Johnson (JNJ) generates a 3.5% free cash flow yield, compared to Thermo Fisher Scientific Inc.'s 3.2%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, Johnson & Johnson or Thermo Fisher Scientific Inc.?

JNJ earns 15.3% ROIC versus TMO's 6.7%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Johnson & Johnson's or Thermo Fisher Scientific Inc.'s?

TMO's dividend earns a safety score of 94/100 (Very Safe), compared to JNJ's 79/100 (Safe). TMO has raised its dividend for 3 consecutive years.

JNJ vs TMO: Which Is the Better Buy in 2026? | SafetyMargin.io